EP 1085873 A1 20010328 - USE OF A NK-1 RECEPTOR ANTAGONIST FOR TREATING PSYCHIATRIC DISORDERS
Title (en)
USE OF A NK-1 RECEPTOR ANTAGONIST FOR TREATING PSYCHIATRIC DISORDERS
Title (de)
VEWRWENDUNG VON NK-1 REZEPTOR ANTAGONISTEN ZUR BEHANDLUNG VON PSYCHIATRISCHEN KRANKHEITEN
Title (fr)
UTILISATION D'ANTAGONISTES DU RECEPTEUR NK-1 DANS LE TRAITEMENT DES TROUBLES PSYCHIATRIQUES
Publication
Application
Priority
- GB 9901797 W 19990608
- GB 9812620 A 19980611
- GB 9812618 A 19980611
- GB 9812616 A 19980611
- GB 9812666 A 19980611
Abstract (en)
[origin: WO9964006A1] The present invention provides the use of a NK-1 receptor antagonist for the manufacture of a medicament for the treatment or prevention of major depressive disorders, severe anxiety disorders, major depressive disorder when present with anxiety or stress disorders without concomitant therapy with other anti-depressant, anti-anxiety or anti-stress agents, methods of treatment using such a NK-1 receptor antagonist and pharmaceutical compositions comprising the same.
IPC 1-7
IPC 8 full level
A61K 31/535 (2006.01); A61K 31/5377 (2006.01); A61P 25/00 (2006.01); A61P 25/22 (2006.01); A61P 25/24 (2006.01); A61P 43/00 (2006.01); C07D 249/02 (2006.01)
CPC (source: EP)
A61K 31/5377 (2013.01); A61P 25/00 (2017.12); A61P 25/22 (2017.12); A61P 25/24 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 9964006A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9964006 A1 19991216; AU 4278199 A 19991230; CA 2334611 A1 19991216; EP 1085873 A1 20010328; JP 2002517446 A 20020618
DOCDB simple family (application)
GB 9901797 W 19990608; AU 4278199 A 19990608; CA 2334611 A 19990608; EP 99955423 A 19990608; JP 2000553075 A 19990608